Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results Director departure
|
Eiger BioPharmaceuticals, Inc. (EIGR)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/14/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/14/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/19/2022 |
3
| Kelly-Croswell Lisa (Director) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
10/01/2021 |
3
| Atkisson Erik (GC & Chief Compliance Officer) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
04/23/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/30/2019 |
3
| Sachdev Amit (Director) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
03/25/2019 |
3
| Patton Stephana Eilene (See Remarks) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
01/09/2019 |
3
| Murray Christine (Director) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
12/27/2018 |
3
| Ryali Sriram (CFO) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
10/25/2018 |
3
| RA CAPITAL MANAGEMENT, LLC (10% Owner) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
01/09/2018 |
3
| Mayer Eldon C. III (Director) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
09/18/2017 |
3
| Loh Evan (Director) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
06/20/2017 |
3
| Apelian David (Director) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
03/31/2016 |
3
| Kjellson Nina S (10% Owner) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
03/31/2016 |
3
| INTERWEST PARTNERS X LP (10% Owner) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
03/28/2016 |
3
| Cory David A (President and CEO) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
03/28/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
03/25/2016 |
3
| ENGLEMAN EDGAR (10% Owner) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
03/25/2016 |
3
| Martins Eduardo Bruno (SVP, Liver and Infectious Dise) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
03/25/2016 |
3
| Glenn Jeffrey S (Director) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
03/25/2016 |
3
| Quan Joanne (Chief Medical Officer) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
03/25/2016 |
3
| Shaffer James P (Chief Business Officer) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
03/25/2016 |
3
| Dietz Thomas John (Director) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
03/25/2016 |
3
| WELCH JAMES H (CFO) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
03/25/2016 |
3
| Bramlage Charles (Director) has filed a Form 3 on Eiger BioPharmaceuticals, Inc. |
|
|